Cel-Sci
CVM
$1.63
Share price
10.14%
Change (1 day)
-32.92%
Change (1 year)
Categories
Earnings for Cel-Sci (CVM)
Earnings in 2023 (TTM): -$30.33 M
According to Cel-Sci 's latest financial reports the company's current earnings (TTM) are -$30.33 M. an increase over its 2022 earnings that were of -$34.82 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Cel-Sci from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$30.33 M | -12.87% |
| 2022 | -$34.82 M | -3.42% |
| 2021 | -$36.05 M | 13.44% |
| 2020 | -$31.78 M | 11.28% |
| 2019 | -$28.56 M | 179.81% |
| 2018 | -$10.21 M | -48.72% |
| 2017 | -$19.9 M | -16.23% |
| 2016 | -$23.76 M | -23.63% |
| 2015 | -$31.11 M | -5.47% |
| 2014 | -$32.91 M | 198.49% |
| 2013 | -$11.03 M | |
| 2010 | -$12.87 M | |
| 2004 | -$4.35 M | 12.38% |
| 2003 | -$3.87 M | -16.59% |
| 2002 | -$4.64 M | -59.28% |
| 2001 | -$11.4 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -56,057.80% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | -25,998.45% | 🇺🇸 USA |
 Xencor XNCR | -$0.13 B | 297.10% | 🇺🇸 USA |
 Curis CRIS | -$43.93 M | 44.83% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -1,435.31% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | -$0.23 B | 645.89% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.65 B | 2,022.65% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$20.53 M | -32.34% | 🇺🇸 USA |